Par Drugs and Chemicals Schedules Board Meeting for Q2 FY27 Results
Par Drugs and Chemicals Ltd 路 Intimation 路 29 Oct 2026, 5:30 am
Par Drugs and Chemicals Schedules Board Meeting for Q2 FY27 Results Par Drugs and Chemicals Limited has scheduled a meeting of its Board of Directors on 29th Oct'26 via video conferencing. Key agenda items include considering and approving the Unaudited Standalone Financial Results along with the Limited Review Report for the quarter and half-year ended 30th Sep'26. Additionally, the board will review the investor grievance report, SEBI SCORES platform status, corporate governance report for the period, and finalize related newspaper advertisement publications.
Original exchange filing (PDF)
More announcements from Par Drugs and Chemicals Ltd
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 29.10.2026'. 路 29 Oct 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 29, 2026. 路 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting results. 路 27 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Proceeding of AGM dated 26.09.2026'. 路 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026 路 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'. 路 01 Sept 2026
